Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Medical Action fiscal 2011 fourth quarter net sales increase 48% to $105,273,000

Medical Action Industries Inc., a supplier of medical and surgical disposable products, today reported fourth quarter and fiscal 2011 results.

25 May 2011

Atmospheric chlorine-content linked to risk of childhood leukaemia

A significant positive association between the risk of childhood leukaemia and levels of chlorine-containing chemicals in the atmosphere has been found by researchers in Portugal. Details are reported in the current issue of the International Journal of Environment and Health.

25 May 2011

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

Biologics Process Development Inc., a wholly-owned subsidiary of Viropro, will double the size of its existing bioprocess- and scale-up laboratory in Poway, CA.

25 May 2011

Tektronix Component Solutions, Vanguard sign Joint Marketing Agreement for microelectronics

Vanguard EMS and Tektronix Component Solutions have signed a Joint Marketing Agreement to formalize their collaboration and the joint offering of their capabilities to customers in the defense, aerospace, medical and industrial equipment markets.

24 May 2011

Sonova sales increase 13.3% to CHF 1,617 million for financial year 2010/11

Sonova consolidated its leading position in the hearing instrument industry in financial year 2010/11. Despite negative currency effects, a new sales record of CHF 1,617 million was achieved.

24 May 2011

An alternative solid phase affinity matrix for chromatin immunoprecipitation

Porvair Filtration Group working in collaboration with the Department of Biological Sciences, University of Essex, UK has produced an alternative, high performance Solid Phase Affinity Matrix for Chromatin Immunoprecipitation (ChIP) assays. The research at Essex University evaluating the new BioVyon - Protein A material in ChIP assays is published in the May 2011 issue of Analytical Biochemistry.

From Chromatrap® - Porvair Sciences Ltd 23 May 2011

Lab21 acquires molecular diagnostics company Myconostica Ltd

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has today announced that it has acquired Myconostica Ltd, a molecular diagnostic company focussing on the diagnosis of fungal infections of clinical importance.

23 May 2011

U.S. District Court grants Cephalon Temporary Restraining Order for generic AMRIX

Today, the United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon, Inc., and Eurand, Inc., for a Temporary Restraining Order (TRO) enjoining Mylan Pharmaceuticals Inc., and Mylan Inc., from manufacturing, using, offering to sell or selling its cyclobenzaprine hydrochloride extended-release capsules, a generic version of Cephalon's branded product AMRIX.

21 May 2011

Local production of pharmaceuticals could improve access in developing countries, U.N. report says

A U.N. Conference on Trade and Development report issued last week suggested "[l]ocal production of pharmaceuticals in some poor African and Asian countries, such as Ethiopia, Uganda, and Bangladesh, has the potential to improve access to essential drugs for many of the one billion people who live in the world's least developed countries," BMJ News writes.

21 May 2011

China Ruitai first quarter 2011 total revenue decreases 6% to $9.6 million

China Ruitai International Holdings Co., Ltd., a manufacturer and distributor of cellulose ether additives for use in the production of pharmaceuticals, construction materials, PVC products, foods and beverages and cosmetics, today announced its results for the three months ended March 31, 2011.

20 May 2011

Neuland Labs fiscal 2011 revenues increase 41% to $88.8 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients, complex intermediates, and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the 2011 fiscal year ended March 31, 2011.

20 May 2011

CSL welcomes historic pandemic agreement

CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. The Framework is the culmination of several years work by a dedicated working group of the World Health Organisation (WHO) and paves the way for greater global collaboration between public and private stakeholders in preparing the world for possible future influenza pandemics.

19 May 2011

Unigene enters Clinical Manufacturing Services Agreement with Cara Therapeutics

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company signed a Clinical Manufacturing Services Agreement with Cara Therapeutics, Inc.

19 May 2011

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

International Stem Cell Corporation has now enrolled the first U.S.-based donor in its program to establish a bank of clinical-grade human parthenogenetic stem cells (hpSCs) capable of being immune-matched to millions of patients.

19 May 2011

ShangPharma first quarter net revenues increase 25.6% to $24.8 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its first quarter ended March 31, 2011.

19 May 2011

Takeda reaches agreement to acquire Nycomed

Takeda Pharmaceutical Company Limited and Nycomed A/S jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis.

19 May 2011

Manufacturing News and Research

Further Reading

Medical Action fiscal 2011 fourth quarter net sales increase 48% to $105,273,000

Atmospheric chlorine-content linked to risk of childhood leukaemia

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

Tektronix Component Solutions, Vanguard sign Joint Marketing Agreement for microelectronics

Sonova sales increase 13.3% to CHF 1,617 million for financial year 2010/11

An alternative solid phase affinity matrix for chromatin immunoprecipitation

Lab21 acquires molecular diagnostics company Myconostica Ltd

U.S. District Court grants Cephalon Temporary Restraining Order for generic AMRIX

Local production of pharmaceuticals could improve access in developing countries, U.N. report says

China Ruitai first quarter 2011 total revenue decreases 6% to $9.6 million

Neuland Labs fiscal 2011 revenues increase 41% to $88.8 million

CSL welcomes historic pandemic agreement

Unigene enters Clinical Manufacturing Services Agreement with Cara Therapeutics

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

ShangPharma first quarter net revenues increase 25.6% to $24.8 million

Takeda reaches agreement to acquire Nycomed

Global health partnership announces first-, second-line AIDS drugs price reductions in developing world

Momentive Performance Materials collaborates with SSF to develop combination products

Cameron Health announces completion of $107 million equity financing round

Affymetrix launches new menu of multiple genomic microarray tools

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy